Lymphoma, Non-Hodgkin
This graph shows the total number of publications written about "Lymphoma, Non-Hodgkin" by people in the URMC Research Network by year, and whether "Lymphoma, Non-Hodgkin" was a major or minor topic of these publication.
Below are the most recent publications written about "Lymphoma, Non-Hodgkin" by people in Profiles.
-
Mahadevan D, Fisher RI. Novel therapeutics for aggressive non-Hodgkin's lymphoma. J Clin Oncol. 2011 May 10; 29(14):1876-84.
-
Kelly JL, Novak AJ, Fredericksen ZS, Liebow M, Ansell SM, Dogan A, Wang AH, Witzig TE, Call TG, Kay NE, Habermann TM, Slager SL, Cerhan JR. Germline variation in apoptosis pathway genes and risk of non-Hodgkin's lymphoma. Cancer Epidemiol Biomarkers Prev. 2010 Nov; 19(11):2847-58.
-
Drake MT, Maurer MJ, Link BK, Habermann TM, Ansell SM, Micallef IN, Kelly JL, Macon WR, Nowakowski GS, Inwards DJ, Johnston PB, Singh RJ, Allmer C, Slager SL, Weiner GJ, Witzig TE, Cerhan JR. Vitamin D insufficiency and prognosis in non-Hodgkin's lymphoma. J Clin Oncol. 2010 Sep 20; 28(27):4191-8.
-
Zadik Y, Vainstein V, Heling I, Neuman T, Drucker S, Elad S. Cytotoxic chemotherapy-induced odontalgia: a differential diagnosis for dental pain. J Endod. 2010 Sep; 36(9):1588-92.
-
Kahl BS, Cheson BD, Friedberg JW. Clinical Roundtable Monograph: current treatment options for NHL patients refractory to standard therapy: recent data in single-agent and combination therapy. Clin Adv Hematol Oncol. 2010 May; 8(5):1-16.
-
Sousou T, Friedberg J. Rituximab in indolent lymphomas. Semin Hematol. 2010 Apr; 47(2):133-42.
-
Caimi PF, Barr PM, Berger NA, Lazarus HM. Non-Hodgkin's lymphoma in the elderly. Drugs Aging. 2010 Mar 1; 27(3):211-38.
-
Cheson BD, Wendtner CM, Pieper A, Dreyling M, Friedberg J, Hoelzer D, Moreau P, Gribben J, Knop S, Montillo M, Rummel M. Optimal use of bendamustine in chronic lymphocytic leukemia, non-Hodgkin lymphomas, and multiple myeloma: treatment recommendations from an international consensus panel. Clin Lymphoma Myeloma Leuk. 2010 Feb; 10(1):21-7.
-
Friedberg JW, Sharman J, Sweetenham J, Johnston PB, Vose JM, Lacasce A, Schaefer-Cutillo J, De Vos S, Sinha R, Leonard JP, Cripe LD, Gregory SA, Sterba MP, Lowe AM, Levy R, Shipp MA. Inhibition of Syk with fostamatinib disodium has significant clinical activity in non-Hodgkin lymphoma and chronic lymphocytic leukemia. Blood. 2010 Apr 1; 115(13):2578-85.
-
Kelly JL, Friedberg JW, Calvi LM, van Wijngaarden E, Fisher SG. Vitamin D and non-Hodgkin lymphoma risk in adults: a review. Cancer Invest. 2009 Nov; 27(9):942-51.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
|
